Douglas Lin, MD PhD (@DougLinMD) header
Douglas Lin, MD PhD (@DougLinMD) profile picture

Senior Pathologist and Associate Medical Director at Foundation Medicine.

Boston, MA
Joined August 2017
Como devia ser no Brasil: as duas torcidas rivais entrando pacientemente no estádio e arquibancadas sem violência.
96
Stop by our booth 152 during #USCAP2023 if you would like to speak with a Foundation Medicine pathologist.
1
9
842
Congratulations Dr. Zong for winning the ISUP certificate of the Excellence Award for this abstract.
2
1
1
6
852
While endometrial serous carcinomas with classic, papillary morphology exhibit lower rates of HRD and fewer mutations of BRCA1/2 and of other genes HRD pathway. – at Cambridge, MA
6
Endometrial serous carcinomas with solid, pseudo-endometrioid or transitional-like morphology. – at Cambridge, MA
1
5
1
8
We present the characterization of BCORL1-driven HG-ESS. Key features included 1) a spindle cell appearance, most often with myxoid stroma, 2) hypocellular fibromyxoid spindle areas with lower grade atypia and 3) epithelioid areas with higher grade atypia. rdcu.be/cpK4y – at Needham, MA
1
15
1
35
We are excited to report the clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma. #GynPath #Immunotherapy #GynOnc #CervicalCancer. Article access link via:  rdcu.be/cfSHv
12
29
4. Malignant Brenner tumor:  Invasive tumors with transitional-type cells often with high-grade atypia resembling bladder high-grade urothelial carcinoma.
1
2
5
3. Borderline Brenner tumor:  papillary architecture with low-grade atypia, no invasion resembling low-grade non-invasive papillary urothelial carcinoma.
1
2
2